Medindia LOGIN REGISTER
Medindia

Side effect(s) of Cemiplimab-rwlc


Review the side-effects of Cemiplimab-rwlc as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the instances these side-effects are mild and easily tolerable, however sometimes they can be more severe and can be detrimental.

If the side effects are not tolerable adjusting the dosage or switching to a different medication can help to manage or overcome side effects. If you have any doubts or questions, we recommend seeking advice from your doctor or pharmacist.

  Gastrointestinal:
Nausea, loose stools, constipation, loss of appetite, pancreatitis, stomach pain, blood in stools, colitis

  Respiratory:
Cough, chest pain, breathing difficulty, pneumonitis

  Skin:
Rash, itching, skin redness, mouth ulcers

  Musculoskeletal:
Muscle pain, back pain, neck pain, pain in the legs or hands

  Lab abnormalities:
Low levels of red blood cells, lymphocytes, albumin, sodium, calcium, and phosphate. High levels of liver enzymes

  Others:
Nephritis, thyroid disorders, type 1 diabetes, hypophysitis or swelling of the pituitary glands, liver damage, abnormal heartbeat, weakness

Other Precautions :

Extreme caution is required while cemiplimab-rwlc is given to the patients who undergo organ transplant or with a history of the following conditions-

• Breathing disorder
• Liver disease
Kidney damage
• Diabetes
• Thyroid disorders
Ulcerative colitis or Crohn’s disease

Drug Name : Cemiplimab-rwlc

FDA-approved Cemiplimab-rwlc injection is used for treating cutaneous squamous cell carcinoma (CSCC), a specific type of skin cancer. It is used in patients with locally advanced or whose cancer cells have moved to other body parts and who cannot undergo surgery or radiation.


Advertisement